IBDEI0CF ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16586,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,16586,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,16587,0)
 ;;=V16.1^^107^962^14
 ;;^UTILITY(U,$J,358.3,16587,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16587,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,16587,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,16587,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,16588,0)
 ;;=V19.6^^107^962^7
 ;;^UTILITY(U,$J,358.3,16588,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16588,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,16588,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,16588,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,16589,0)
 ;;=V18.2^^107^962^8
 ;;^UTILITY(U,$J,358.3,16589,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16589,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,16589,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,16589,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,16590,0)
 ;;=V17.5^^107^962^10
 ;;^UTILITY(U,$J,358.3,16590,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16590,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,16590,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,16590,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,16591,0)
 ;;=V17.7^^107^962^9
 ;;^UTILITY(U,$J,358.3,16591,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16591,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,16591,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,16591,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,16592,0)
 ;;=V19.0^^107^962^11
 ;;^UTILITY(U,$J,358.3,16592,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16592,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,16592,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,16592,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,16593,0)
 ;;=V16.3^^107^962^12
 ;;^UTILITY(U,$J,358.3,16593,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16593,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,16593,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,16593,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,16594,0)
 ;;=V16.41^^107^962^15
 ;;^UTILITY(U,$J,358.3,16594,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16594,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,16594,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,16594,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,16595,0)
 ;;=V16.42^^107^962^16
 ;;^UTILITY(U,$J,358.3,16595,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16595,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,16595,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,16595,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,16596,0)
 ;;=V16.43^^107^962^17
 ;;^UTILITY(U,$J,358.3,16596,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16596,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,16596,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,16596,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,16597,0)
 ;;=V19.5^^107^962^19
 ;;^UTILITY(U,$J,358.3,16597,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16597,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,16597,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,16597,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,16598,0)
 ;;=V19.2^^107^962^20
 ;;^UTILITY(U,$J,358.3,16598,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16598,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,16598,1,5,0)
 ;;=5^Family h/o Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,16598,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,16599,0)
 ;;=V17.3^^107^962^23
 ;;^UTILITY(U,$J,358.3,16599,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16599,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,16599,1,5,0)
 ;;=5^Family h/o Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,16599,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,16600,0)
 ;;=V16.6^^107^962^24
 ;;^UTILITY(U,$J,358.3,16600,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16600,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,16600,1,5,0)
 ;;=5^Family h/o Leukemia
 ;;^UTILITY(U,$J,358.3,16600,2)
 ;;=^295298
 ;;^UTILITY(U,$J,358.3,16601,0)
 ;;=V18.61^^107^962^27
 ;;^UTILITY(U,$J,358.3,16601,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16601,1,4,0)
 ;;=4^V18.61
 ;;^UTILITY(U,$J,358.3,16601,1,5,0)
 ;;=5^Family h/o Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,16601,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,16602,0)
 ;;=V17.0^^107^962^28
 ;;^UTILITY(U,$J,358.3,16602,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16602,1,4,0)
 ;;=4^V17.0
 ;;^UTILITY(U,$J,358.3,16602,1,5,0)
 ;;=5^Family h/o Psychiatric Condition
 ;;^UTILITY(U,$J,358.3,16602,2)
 ;;=^295302
 ;;^UTILITY(U,$J,358.3,16603,0)
 ;;=V19.4^^107^962^29
 ;;^UTILITY(U,$J,358.3,16603,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16603,1,4,0)
 ;;=4^V19.4
 ;;^UTILITY(U,$J,358.3,16603,1,5,0)
 ;;=5^Family h/o Skin Condition
 ;;^UTILITY(U,$J,358.3,16603,2)
 ;;=^295324
 ;;^UTILITY(U,$J,358.3,16604,0)
 ;;=V17.1^^107^962^30
 ;;^UTILITY(U,$J,358.3,16604,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16604,1,4,0)
 ;;=4^V17.1
 ;;^UTILITY(U,$J,358.3,16604,1,5,0)
 ;;=5^Family h/o Stroke (Cerebrovascular)
 ;;^UTILITY(U,$J,358.3,16604,2)
 ;;=^295303
 ;;^UTILITY(U,$J,358.3,16605,0)
 ;;=V16.8^^107^962^26
 ;;^UTILITY(U,$J,358.3,16605,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16605,1,4,0)
 ;;=4^V16.8
 ;;^UTILITY(U,$J,358.3,16605,1,5,0)
 ;;=5^Family h/o Other Specified Cancer
 ;;^UTILITY(U,$J,358.3,16605,2)
 ;;=^295300
 ;;^UTILITY(U,$J,358.3,16606,0)
 ;;=V11.1^^107^962^35
 ;;^UTILITY(U,$J,358.3,16606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16606,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,16606,1,5,0)
 ;;=5^Personal h/o Affective Disorder
 ;;^UTILITY(U,$J,358.3,16606,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,16607,0)
 ;;=V15.89^^107^962^49
 ;;^UTILITY(U,$J,358.3,16607,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16607,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,16607,1,5,0)
 ;;=5^Personal h/o Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,16607,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,16608,0)
 ;;=V11.3^^107^962^36
 ;;^UTILITY(U,$J,358.3,16608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16608,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,16608,1,5,0)
 ;;=5^Personal h/o Alcoholism
 ;;^UTILITY(U,$J,358.3,16608,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,16609,0)
 ;;=V15.07^^107^962^37
 ;;^UTILITY(U,$J,358.3,16609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16609,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,16609,1,5,0)
 ;;=5^Personal h/o Allerlgy to Latex
 ;;^UTILITY(U,$J,358.3,16609,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,16610,0)
 ;;=V13.4^^107^962^38
 ;;^UTILITY(U,$J,358.3,16610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16610,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,16610,1,5,0)
 ;;=5^Personal h/o Arthritis
 ;;^UTILITY(U,$J,358.3,16610,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,16611,0)
 ;;=V12.59^^107^962^43
 ;;^UTILITY(U,$J,358.3,16611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16611,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,16611,1,5,0)
 ;;=5^Personal h/o Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,16611,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,16612,0)
 ;;=V45.81^^107^962^44
 ;;^UTILITY(U,$J,358.3,16612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16612,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,16612,1,5,0)
 ;;=5^Personal h/o Coronary Bypass
 ;;^UTILITY(U,$J,358.3,16612,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,16613,0)
 ;;=V15.84^^107^962^48
 ;;^UTILITY(U,$J,358.3,16613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16613,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,16613,1,5,0)
 ;;=5^Personal h/o Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,16613,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,16614,0)
 ;;=V15.85^^107^962^68
 ;;^UTILITY(U,$J,358.3,16614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16614,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,16614,1,5,0)
 ;;=5^Personal h/o Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,16614,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,16615,0)
 ;;=V10.72^^107^962^52
 ;;^UTILITY(U,$J,358.3,16615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16615,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,16615,1,5,0)
 ;;=5^Personal h/o Hodgkin's Disease
 ;;^UTILITY(U,$J,358.3,16615,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,16616,0)
 ;;=V15.3^^107^962^53
 ;;^UTILITY(U,$J,358.3,16616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16616,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,16616,1,5,0)
 ;;=5^Personal h/o Irradiation
 ;;^UTILITY(U,$J,358.3,16616,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,16617,0)
 ;;=V10.82^^107^962^60
 ;;^UTILITY(U,$J,358.3,16617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16617,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,16617,1,5,0)
 ;;=5^Personal h/o Mal Melanoma of Skin
 ;;^UTILITY(U,$J,358.3,16617,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,16618,0)
 ;;=V15.81^^107^962^34
 ;;^UTILITY(U,$J,358.3,16618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16618,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,16618,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,16618,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,16619,0)
 ;;=V10.43^^107^962^66
 ;;^UTILITY(U,$J,358.3,16619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16619,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,16619,1,5,0)
 ;;=5^Personal h/o Ovarian Cancer
 ;;^UTILITY(U,$J,358.3,16619,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,16620,0)
 ;;=V10.46^^107^962^69
 ;;^UTILITY(U,$J,358.3,16620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16620,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,16620,1,5,0)
 ;;=5^Personal h/o Prostate Cancer
 ;;^UTILITY(U,$J,358.3,16620,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,16621,0)
 ;;=V10.83^^107^962^74
 ;;^UTILITY(U,$J,358.3,16621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16621,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,16621,1,5,0)
 ;;=5^Personal h/o Skin Cancer
 ;;^UTILITY(U,$J,358.3,16621,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,16622,0)
 ;;=V15.1^^107^962^51
 ;;^UTILITY(U,$J,358.3,16622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,16622,1,5,0)
 ;;=5^Personal h/o Heart Surgery
